fda approval for semaglutide The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing FDA has approved a new,

Consistency across vial sizes eliminates confusion when you switch between them or compare notes with others using different vial sizes

In clinical studies, people have lost up to 14.9% of their body weight after 68 weeks on Wegovy

The most successful patients pair their weekly injections with a real lifestyle change

What we do not know (yet) -A large, powered randomized clinical trial in humans with a robust effect size for GLP-1RA in any formal substance use disorder

We saw GLP-1 medications as a breakthrough but noticed a lack of support systems around them. We built Fridays to be more than a prescription its a full-circle program rooted in education, coaching, and accessible care. Fridays is a white-label telehealth provider Like many companies offering GLP-1 medication, Fridays is a white-label telehealth provider under OpenLoop Healthcare Partners

For retatrutide specifically, Phase 3 trial data are still being collected and analysed